McDonald B L, Dawkins R L, Holborow E J
Clin Exp Immunol. 1977 Feb;27(2):269-72.
In 1965 Johnson, Holborow & Glynn showed that some patients with chronic liver disease have antibodies which react with smooth muscle by indirect immunofluorescence. This work was rapidly confirmed and it was soon showed that the same serum may also react with renal glomeruli and other tissue components. Reactions with skeletal muscle were not demonstrated. In 1960 Strauss and co-workers deomonstrated that patients with myasthenia gravis may have antibodies which react with skeletal muscle. Subsequent work has suggested that these antibodies are specific for skeletal as opposed to smooth muscle. More recently smooth muscles antibodies (SMA) have been shown to react with a wide range of tissues and cells including neoplastic cells (Gabbiani et al,, 1973; Holborow et al., 1975). Throughout this work it has been assumed that such reactivity is due to the presence of smooth muscle contractile proteins. This conclusion was further supported by the demonstration that animals immunized with smooth muscle contractile proteins developed antibodies which produce similar patterns to those found with the naturally occurring antismooth muscle antibodies (Trenchev, Sneyd & Holborow, 1974). From these studies it appeared that there was very little if any cross reactivity between smooth and skeletal muscle, although Bray (1974) pointed to the need to re-examine this conclusion. In the course of screening human sera for autoantibodies we have been impressed by the occasional occurrence of sera which gave both smooth and skeletal muscle staining patterns. In this report we describe selected sera which react with antigens which appear specific for either smooth or striated muscle, and additional sera which react with antigens which appear common to both smooth and striated muscle. Immunization of rabbits with skeletal muscle contractile protein has provided further evidence for such cross reactivity,
1965年,约翰逊、霍尔博罗和格林发现,一些慢性肝病患者体内存在可通过间接免疫荧光与平滑肌发生反应的抗体。这项研究很快得到证实,并且很快发现同一血清也可能与肾小球及其他组织成分发生反应。未证实与骨骼肌有反应。1960年,施特劳斯及其同事证明,重症肌无力患者体内可能存在与骨骼肌发生反应的抗体。随后的研究表明,这些抗体对骨骼肌具有特异性,与平滑肌不同。最近发现,平滑肌抗体(SMA)可与包括肿瘤细胞在内的多种组织和细胞发生反应(加比亚尼等人,1973年;霍尔博罗等人,1975年)。在整个研究过程中,人们一直认为这种反应性是由于平滑肌收缩蛋白的存在。用平滑肌收缩蛋白免疫动物后产生的抗体与天然存在的抗平滑肌抗体产生相似的反应模式,这一发现进一步支持了这一结论(特伦切夫、斯内德和霍尔博罗,1974年)。从这些研究来看,平滑肌和骨骼肌之间几乎没有交叉反应,尽管布雷(1974年)指出有必要重新审视这一结论。在筛选人血清中的自身抗体过程中,我们对偶尔出现的既能使平滑肌又能使骨骼肌呈现染色模式的血清印象深刻。在本报告中,我们描述了与平滑肌或横纹肌特异性抗原发生反应的选定血清,以及与平滑肌和横纹肌共同抗原发生反应的其他血清。用骨骼肌收缩蛋白免疫兔子为这种交叉反应提供了进一步的证据。